Olema Pharmaceuticals, Inc. Common Stock (OLMA)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 137
- Market Cap
- $1.0B
About Olema Pharmaceuticals, Inc. Common Stock
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
SentiSense also tracks daily options readings for Olema Pharmaceuticals, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Olema Pharmaceuticals, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.